Connect with us

Hi, what are you looking for?

Right Decision NowRight Decision Now

World News

Canada says bulk importation not an effective solution to high drug prices in US

The Canadian government thinks bulk importation will not provide an effective solution to the problem of high drug prices in the United States after the US Food and Drug Administration allowed Florida to import cheaper drugs from Canada, Health Canada said on Monday.

 

WHY IT’S IMPORTANT

US drug costs are higher than in Canada and other countries where government-run healthcare systems negotiate prices for individual prescription drugs.

Florida on Friday won authorization from the FDA to directly import prescription drugs from Canada, the first state to get such approval for a strategy that could lower prices for medicines.

 

KEY QUOTES

“The Government of Canada is taking all necessary action to safeguard the drug supply and ensure Canadians have access to the prescription drugs they need and has been clear in its position: bulk importation will not provide an effective solution to the problem of high drug prices in the US,” Health Canada said in a statement.

The statement noted regulations to prohibit certain drugs intended for the Canadian market from being sold for consumption outside of Canada if that sale could cause a drug shortage in Canada.

“The Department will not hesitate to take immediate action to address non-compliance, ranging from requesting a plan for corrective measures, issuing a public advisory or other forms of communication, to taking action on the licenses of regulated parties who contravene the export prohibition if warranted.”

 

CONTEXT

In the past, Canada’s government has opposed any US plans to buy prescription medicines, citing threats to the country’s drugs supply or higher costs for its own citizens.

For years, US supporters of importation policy have said buying drugs from elsewhere could help lower costs in the U.S., where more than half of Americans are covered by private health plans.

Florida still needs to submit drug-specific information for FDA review and approval as well as evidence that the drugs it seeks to import have been tested to comply with FDA standards, the agency said. – Reuters

    You May Also Like

    Business

    The head of the International Monetary Fund has warned of increased risks to the stability of the financial system after weeks of banking sector...

    World News

    BEIJING — China landed an uncrewed spacecraft on the far side of the moon on Sunday, overcoming a key hurdle in its landmark mission...

    World News

    LONDON — Talks aimed at reaching a global agreement on how to better fight pandemics will be concluded by 2025 or earlier if possible,...

    World News

    SINGAPORE — Ukrainian President Volodmyr Zelensky’s unscheduled appearance at Asia’s biggest security conference dominated proceedings on Sunday after China’s defense chief slammed “separatists” in...

    Disclaimer: rightdecisionnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 rightdecisionnow.com | All Rights Reserved